
### [NCIT:C7607](http://purl.obolibrary.org/obo/NCIT_C7607)
**Label:** Benign Oral Cavity Neoplasm

**Subclasses:** [NCIT:C5910](http://purl.obolibrary.org/obo/NCIT_C5910) (Oral Cavity Lipoma), [NCIT:C7605](http://purl.obolibrary.org/obo/NCIT_C7605) (Oral Cavity Benign Granular Cell Tumor), [NCIT:C6845](http://purl.obolibrary.org/obo/NCIT_C6845) (Oral Cavity Monomorphic Adenoma), [NCIT:C27478](http://purl.obolibrary.org/obo/NCIT_C27478) (Gingival Angiofibroma), [NCIT:C5913](http://purl.obolibrary.org/obo/NCIT_C5913) (Oral Cavity Adenoma), [NCIT:C4406](http://purl.obolibrary.org/obo/NCIT_C4406) (Benign Buccal Mucosa Neoplasm), [NCIT:C4598](http://purl.obolibrary.org/obo/NCIT_C4598) (Benign Gingival Neoplasm), [NCIT:C3950](http://purl.obolibrary.org/obo/NCIT_C3950) (Oral Mucosa Lobular Capillary Hemangioma), [NCIT:C4831](http://purl.obolibrary.org/obo/NCIT_C4831) (Gingival Hemangioma), [NCIT:C7734](http://purl.obolibrary.org/obo/NCIT_C7734) (Tongue Lipoma), [NCIT:C6063](http://purl.obolibrary.org/obo/NCIT_C6063) (Benign Anterior Tongue Neoplasm), [NCIT:C3593](http://purl.obolibrary.org/obo/NCIT_C3593) (Benign Floor of the Mouth Neoplasm), [NCIT:C6242](http://purl.obolibrary.org/obo/NCIT_C6242) (Oral Cavity Pleomorphic Adenoma), [NCIT:C3592](http://purl.obolibrary.org/obo/NCIT_C3592) (Benign Tongue Neoplasm), [NCIT:C5819](http://purl.obolibrary.org/obo/NCIT_C5819) (Buccal Mucosa Papilloma), [NCIT:C5909](http://purl.obolibrary.org/obo/NCIT_C5909) (Oral Cavity Leiomyoma), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 40.91%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 40.91%


